BlackRock Institutional Trust’s Cellular Biomedicine Group, Inc. CBMG Stock Holding History

BlackRock Institutional Trust’s Portfolio CBMG Stock Details CBMG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$2.17M	Hold	165,541	–	–	﹤0.01%	3024
2016 Q3	$2.4M	Sell	165,541 -4,261	-3%	-$60.5K	﹤0.01%	2980
2016 Q2	$2.04M	Buy	169,802 +13,722	+9%	+$220K	﹤0.01%	3029
2016 Q1	$2.91M	Buy	156,080 +3,429	+2%	+$56.8K	﹤0.01%	2893
2015 Q4	$3.28M	Buy	152,651 +7,970	+6%	+$168K	﹤0.01%	2910
2015 Q3	$2.45M	Buy	144,681 +45,975	+47%	+$1.14M	﹤0.01%	3042
2015 Q2	$3.7M	Buy	98,706 +92,003	+1,373%	+$2.97M	﹤0.01%	2876
2015 Q1	$211K	Buy	6,703 +5,903	+738%	+$160K	﹤0.01%	3632
2014 Q4	$10K	Hold	800	–	–	﹤0.01%	3861
2014 Q3	$17K	Buy	+800	New	+$16.3K	﹤0.01%	3778

Other funds holding CBMG

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BIM

BlackRock Investment Management Wilmington, Delaware $86.4B AUM 16.83% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BlackRock Institutional Trust's CBMG Position: Q4 2016 in Review

BlackRock Institutional Trust held its Cellular Biomedicine Group, Inc. (CBMG) position steady in Q4 2016 at 165,541 shares worth $2.17M. The position accounts for ﹤0.01% of the portfolio, ranked #3024.

BlackRock Institutional Trust first reported a position in CBMG in Q3 2014 and has held it in 10 quarters since. The position peaked at $3.7M in Q2 2015. 38 funds tracked by Wall St. Rank hold CBMG as of Q4 2016.

BlackRock Institutional Trust held 165,541 shares of Cellular Biomedicine Group, Inc. worth $2.17M as of Q4 2016.
BlackRock Institutional Trust left its Cellular Biomedicine Group, Inc. share count unchanged in Q4 2016.
Cellular Biomedicine Group, Inc. made up ﹤0.01% of BlackRock Institutional Trust's portfolio in Q4 2016, its #3024 holding.
BlackRock Institutional Trust first reported a position in Cellular Biomedicine Group, Inc. in Q3 2014 and has held it in 10 quarters since.
BlackRock Institutional Trust's Cellular Biomedicine Group, Inc. position peaked at $3.7M in Q2 2015.
38 funds tracked by Wall St. Rank held Cellular Biomedicine Group, Inc. as of Q4 2016.

Based on BlackRock Institutional Trust's 13F filing for Q4 2016, filed 10 Feb 2017.